Beta-Blockers Show Varied Effects on Hypoglycemic Mortality Risk in Diabetes
Investigators examined the relationship between the use of β-blockers and incidence of hypoglycemia and risk for mortality in hospitalized patients with diabetes.
Investigators examined the relationship between the use of β-blockers and incidence of hypoglycemia and risk for mortality in hospitalized patients with diabetes.
For the analysis, study authors looked at data specifically for patients with type 2 diabetes aged 60 to 70 years.
Investigators analyzed real world data to examine the risk for below-knee amputations in patients with type 2 diabetes taking canagliflozin vs other medications.